AMI Asset Management

AMI Asset Management Investment Perspective

Business EN ↓ 103 episodes

Join AMI Asset Management's Investment Team as they discuss topics impacting the equity markets and economy. Guest speakers include:Chris Sessing, CFA, Chief Investment OfficerAndy Zamfotis, CFA, Equity Portfolio ManagerRichard Schimbor, CFA, Senior Equity AnalystAndrhe Cunha, Equity AnalystDan Schniedwind, CFA, Managing Director of Fixed IncomeAMI Asset Management is a SEC Registered Investment Advisor based in Los Angeles and founded in 1994. The firm manages Domestic Growth Equities and Fixed Income assets on behalf of high-net-worth individuals and institutional investors.

Be sure to visit the podcast's website and support the creator: www.amiassetmanagement.com

Author

AMI Asset Management

Category

Business

Podcast website

www.amiassetmanagement.com

Latest episode

Nov 13, 2026

Where to listen?

Podcasts in the app Replaio Radio Coming soon

Podcasts are coming to the app soon. Install now and be the first to see a whole new take on podcasts

Get it on Google Play Install for free Android 10M+ downloads · 4.7+ rating iOS soon

Episodes

Prediction Markets Are Changing the Game 13.11.2026

In this episode, the team discusses the rapid growth of prediction markets and their increasing competition with traditional online sports betting platforms. The discussion examines how companies such as Kalshi and Polymarket are attracting trading volume, why DraftKings and FanDuel are investing in competing offerings, and how professional sports leagues are approaching the emerging market. The t...

The Election's Ripple Effect Across Markets 06.11.2026

In this episode, the team discusses how the November U.S. election results and the subsequent market volatility are influencing the outlook across major equity sectors. The discussion examines potential implications for healthcare funding, financial institutions, and the AI infrastructure buildout, including growing scrutiny of data center development and electricity costs. The team also explores...

The New Roadblocks to AI's Buildout 06.11.2026

In this episode, the team discusses how the recent U.S. election and growing scrutiny of data center development are reshaping the outlook for AI infrastructure investment. The discussion examines why major cloud platforms have held up better than semiconductor and infrastructure suppliers, despite concerns about permitting delays, electricity costs, and potential restrictions on new construction....

Medical Breakthroughs: New Hope in Cancer and Kidney Disease 30.10.2026

In this episode of AMI Investment Perspective, Chris Sessing, CIO and Portfolio Manager, discusses promising medical breakthroughs highlighted at recent oncology and kidney conferences. Topics include Merck and Moderna’s personalized cancer vaccine, advancements in targeted cancer therapies, and new treatments for IgA nephropathy that could significantly slow kidney disease progression. Chris expl...

The Global Fuel Supply Squeeze 16.10.2026

In this episode, the team discusses the forces driving fuelprices higher and why rising costs at the pump cannot be explained by crude oil prices alone. The discussion examines how tightening refining capacity, China's restrictions on fuel exports, and disruptions to Russian supply are contributing to higher gasoline and diesel prices. The team also explores thegeopolitical risks surrounding t...

AI's Next Bottleneck: Keeping the Lights On 09.10.2026

In this episode, the team discusses several developments shaping the technology and AI investment landscape, including the growing importance of energy infrastructure in supporting AI expansion. The team examines why power availability, grid connections, and equipment shortages may pose greater near-term challenges to data center development than AI regulation itself. The discussion also explores...

“Order My Usual”: The Next Phase of E-Commerce 02.10.2026

In this episode, the team discusses how a new generation of AI agents could change the way consumers shop online. The team examines what happens when consumers can delegate purchases to an agent, from finding the best price and completing transactions to handling recurring everyday purchases. The discussion explores whether removing friction could expand consumer spending, which retailers and inte...

Bonds Are Paying Investors Again? 25.09.2026

In this episode, the team discusses the significant repricing that has taken place across the bond market in 2026 and the forces driving yields higher. The team examines the Federal Reserve’s renewed focus on inflation, the different pressures affecting the short and long ends of the yield curve, and how government borrowing and growing corporate debt issuance are influencing supply and demand. Th...

The AI Pause That Probably Isn’t 18.09.2026

In this episode, the team discusses the growing debate over whether the development of advanced AI should slow down and what that could mean for investors. The team examines recent calls for stronger safety measures, the practical challenges of coordinating an AI slowdown, and the important distinction between training new models and deploying the models that already exist. The discussion also exp...

What Happens When AI Starts Shopping for You? 11.09.2026

In this episode, the team discusses the latest signals on the health of the U.S. consumer as spending data, sentiment, and company commentary continue to paint a mixed picture. The team examines rising inflation concerns, competitive pressures across retail and consumer staples, and how higher gas prices could influence spending heading into the end of the year. The discussion also explores how AI...

The $2 Trillion Problem Facing the Bond Market 04.09.2026

In this episode, the team discusses the recent rise in Treasury yields and the combination of forces putting upward pressure on interest rates. The team examines U.S. deficit spending, inflation and energy prices, Federal Reserve policy, global debt markets, and the growing supply of corporate debt tied to the AI infrastructure buildout. The discussion also explores how higher yields affect both f...

The Price War for the American Consumer 21.08.2026

In this episode, the team discusses the increasingly mixed picture of the U.S. consumer as retail sales, confidence data, credit card spending, and recent retailer earnings send conflicting signals. The team examines signs of greater price sensitivity and trade-down behavior alongside areas where spending remains resilient, including back-to-school activity and select retail categories. The discus...

AI Has a Power Problem. Who Pays for It? 14.08.2026

In this episode, the team discusses how the rapid expansion of data centers is reshaping electricity demand, utility infrastructure spending, and the cost of power for consumers. The team examines the growing debate over who should pay for new generation and grid infrastructure, along with the regulatory and political response emerging across several states. The discussion explores how technology...

Bad News, Good Market? What the Jobs Report Means for the Fed 07.08.2026

In this episode, the team discusses the July employment report and the signs of weakening beneath the headline unemployment rate. The team examines declining labor force participation, the shift from full-time to part-time employment, the rise in multiple job holders, and why the current environment increasingly resembles a low-hiring, low-firing labor market. The discussion also explores the chal...

Is the AI Trade Back? Three Tests That Matter 31.07.2026

In this episode, the team discusses the sharp reversal in AI infrastructure stocks, the role of crowded positioning and leverage, and why strong company results initially failed to support share prices. The team examines how forced selling across U.S. and South Korean markets distorted price signals, even as demand, backlogs, and cloud growth remained strong. The conversation also explores whether...

Beyond Ozempic: The Next-Generation Weight-Loss Peptides Coming in 2027 24.07.2026

In this episode, the team discusses the emerging gray market for medical peptides, highlighting popular compounds like BPC-157, GLP-1 alternatives, and next-generation weight-loss therapies like retatrutide. They unpack the ongoing FDA Pharmacy Compounding Advisory Committee meeting, evaluating the regulatory push-and-pull around allowing 503A compounding pharmacies to produce these compounds safe...

The AI Discernment Phase: The Era of 'Spend at All Costs' Is Over 17.07.2026

In this episode, the team discusses the transition of the artificial intelligence trade into the "discernment phase," analyzing a volatile week where record-breaking hardware earnings met a massive tech sell-off. The team unpacks how historic pre-announcements from legacy giants are revealing a reallocation of corporate IT budgets away from software and into crucial hardware, physical gr...

Nike, Pepsi, and the Battle for a Strained Consumer 10.07.2026

In this episode, the team discusses the shifting state ofthe American consumer as major companies report mixed results heading into the critical back-to-school shopping season. The team analyzes corporate updates from brands like Nike and Pepsi, highlighting a worrying trend where recent price cuts have failed to stimulate positive consumer traffic or volume growth. They unpack how elevated gas pr...

Did the AI Tech Spend Just Hit a Wall? 26.06.2026

In this episode, the team discusses how the rapid build-out of artificial intelligence infrastructure is hitting its first major financial constraints, driven primarily by a massive structural shortage and skyrocketing costs in the memory chip market. The team explores how these rising input costs are trickling down to consumers through hardware price hikes from tech giants like Apple and Microsof...

The U.S.-Iran Deal: Energy Markets, Inflation, Elections and the Natural Gas Opportunity 18.06.2026

In this episode, the team discusses the signing of a breakthrough 14-point interim agreement between the U.S. and Iran, aimed at ending Iran's nuclear program and normalizing trade in a critical energy region. They unpack the immediate, divergent reactions across commodities, where oil prices slumped on potential surplus expectations while Texas natural gas prices finally surged back into posi...

Free Pizza and Grimace Collectibles: How Restaurants Are Hustling for a Short-Term Sales Bump 12.06.2026

In this episode, the team discusses the kickoff of the historic 2026 World Cup in North America, analyzing its massive $13 billion revenue projection and $10 billion advertising splash against surprising domestic apathy and low brand engagement. They break down the tournament's potential investment catalysts across retail, dining, and hospitality, detailing the near-term wholesale boosts for s...

The First Real Crack: What Happens When AI Buyers Refuse to Pay the Bill? 05.06.2026

In this episode, the team discusses a pivotal week in the technology sector where a new market regime has emerged, punishing record-breaking corporate earnings whenever they fail to surpass vertical expectations. They break down the massive hardware shifts coming out of Computex, including NVIDIA’s next-gen Vera Rubin platform, its tactical push into ARM-based AI PCs, and the massive valuation rip...

Rate Hikes Back on the Table? How a Supply Shock is Forcing the Fed's Hand 29.05.2026

In this episode, the team discusses the macro forces driving the markets to all-time highs, examining the persistent debate around an AI tech bubble versus the sector's robust profitability. They explore a recent revival in software stocks, looming liquidity tests from upcoming high-profile tech IPOs, and imminent pricing and usage limit shifts for large language models. The team also breaks d...

ARM’s Silent Victory: The Hidden Chip Powering NVIDIA’s Next Generation 22.05.2026

In this episode, the team discusses a critical week of market-moving earnings across both the retail sector and the tech industry, anchored by a deeply insightful analysis of a massive report from NVIDIA. They break down a stark disconnect in the retail space, where consumer sentiment has sunk to historic lows but companies like Target, Walmart, and off-price leaders are managing to deliver highly...

The Peptide Revolution: Why “Ozempic” Is Just the Tip of the Iceberg 15.05.2026

In this episode, the team discusses the rapid evolution ofthe anti-obesity medication market, tracing the history of GLP-1s from their origins in Gila monster saliva to the current dominance of brands like Ozempic and Mounjaro. They analyze the shifting landscape of drug delivery, includingthe rise of oral alternatives and upcoming "triple-action"medications that aim to balance higher ef...

Listen to the AMI Asset Management Investment Perspective podcast in Replaio

Radio and podcasts in one app - free, with no sign-up. Install today and do not miss the launch

Get it on Google Play

Replaio is not a podcast publisher; show names, artwork and audio belong to their authors and are distributed through public RSS feeds.